×
Entrez Id:
8878
Gene Symbol:
SQSTM1
SQSTM1
0.310
GeneticVariation
disease
BEFREE
SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis .
24042580
2013
×
Entrez Id:
203228
Gene Symbol:
C9orf72
C9orf72
0.310
GeneticVariation
disease
BEFREE
The study examined whether there are clinical differences between FTD-ALS patients with and without expansions in C9orf72 .
23421625
2013
×
Entrez Id:
8878
Gene Symbol:
SQSTM1
SQSTM1
0.310
Biomarker
disease
CTD_human
Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism.
19765191
2009
×
Entrez Id:
203228
Gene Symbol:
C9orf72
C9orf72
0.310
Biomarker
disease
CTD_human
Genetic variation associated with the occurrence and progression of neurological disorders.
27713094
2017
×
Entrez Id:
2936
Gene Symbol:
GSR
GSR
0.300
Biomarker
disease
CTD_human
Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients.
16681429
2006
×
Entrez Id:
6647
Gene Symbol:
SOD1
SOD1
0.300
Biomarker
disease
CTD_human
Resveratrol treatment reduces the vulnerability of SH-SY5Y cells and cortical neurons overexpressing SOD1-G93A to Thimerosal toxicity through SIRT1/DREAM/PDYN pathway.
30503815
2019
×
Entrez Id:
755
Gene Symbol:
CFAP410
CFAP410
0.300
Biomarker
disease
CTD_human
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.
27455348
2016
×
Entrez Id:
6529
Gene Symbol:
SLC6A1
SLC6A1
0.300
Biomarker
disease
CTD_human
In vitro activation of GAT1 transporters expressed in spinal cord gliosomes stimulates glutamate release that is abnormally elevated in the SOD1/G93A(+) mouse model of amyotrophic lateral sclerosis.
20132478
2010
×
Entrez Id:
23435
Gene Symbol:
TARDBP
TARDBP
0.300
Biomarker
disease
CTD_human
Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models.
23104007
2012
×
Entrez Id:
10280
Gene Symbol:
SIGMAR1
SIGMAR1
0.300
Biomarker
disease
CTD_human
Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G⁹³A ALS mice: overlapping effects or limited therapeutic opportunity?
24885036
2014
×
Entrez Id:
25978
Gene Symbol:
CHMP2B
CHMP2B
0.300
Biomarker
disease
CTD_human
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B).
16807408
2006
×
Entrez Id:
6647
Gene Symbol:
SOD1
SOD1
0.300
Biomarker
disease
CTD_human
Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G⁹³A ALS mice: overlapping effects or limited therapeutic opportunity?
24885036
2014
×
Entrez Id:
6647
Gene Symbol:
SOD1
SOD1
0.300
Biomarker
disease
CTD_human
Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells.
18233996
2008
×
Entrez Id:
6647
Gene Symbol:
SOD1
SOD1
0.300
Biomarker
disease
CTD_human
Mutant SOD1 knockdown in all cell types ameliorates disease in G85R SOD1 mice with a limited additional effect over knockdown restricted to motor neurons.
20132483
2010
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
0.300
Biomarker
disease
CTD_human
Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis.
11220737
2001
×
Entrez Id:
23256
Gene Symbol:
SCFD1
SCFD1
0.300
Biomarker
disease
CTD_human
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.
27455348
2016
×
Entrez Id:
6506
Gene Symbol:
SLC1A2
SLC1A2
0.300
Biomarker
disease
CTD_human
Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels.
11723166
2001
×
Entrez Id:
6647
Gene Symbol:
SOD1
SOD1
0.300
Biomarker
disease
CTD_human
Disrupted zinc-binding sites in structures of pathogenic SOD1 variants D124V and H80R.
20515040
2010
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
0.300
Biomarker
disease
CTD_human
Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis.
15816863
2005
×
Entrez Id:
5444
Gene Symbol:
PON1
PON1
0.300
Biomarker
disease
CTD_human
Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown.
28070599
2017
×
Entrez Id:
23025
Gene Symbol:
UNC13A
UNC13A
0.300
Biomarker
disease
CTD_human
Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis.
19734901
2009
×
Entrez Id:
6311
Gene Symbol:
ATXN2
ATXN2
0.300
Biomarker
disease
CTD_human
Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis.
27377857
2017
×
Entrez Id:
2950
Gene Symbol:
GSTP1
GSTP1
0.300
Biomarker
disease
CTD_human
Activity and expression of glutathione S-transferase pi in patients with amyotrophic lateral sclerosis.
16109392
2006
×
Entrez Id:
23435
Gene Symbol:
TARDBP
TARDBP
0.300
Biomarker
disease
CTD_human
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis.
18372902
2008
×
Entrez Id:
6647
Gene Symbol:
SOD1
SOD1
0.300
Biomarker
disease
CTD_human
Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
23583883
2013